Linezolid Krka D.D.

Linezolid, the active ingredient in Linezolid Krka D.D., is an oxazolidinone antibiotic presented as an oral dosage form for oral use. It treats complicated skin and soft tissue infections, community‑acquired bacterial pneumonia, infections caused by methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE) and other serious Gram‑positive bacterial infections in adult patients.

GNH USA supplies Linezolid Krka D.D. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by resistant Gram‑positive bacteria.

- Complicated skin and soft tissue infections: provides bacterial eradication and clinical cure in resistant skin infections. - Community‑acquired bacterial pneumonia: effective against typical and atypical pathogens, improving respiratory outcomes. - MRSA infections: offers an alternative to vancomycin for methicillin‑resistant Staphylococcus aureus. - VRE infections: active against vancomycin‑resistant Enterococcus species. - Other serious Gram‑positive infections: treats infections such as endocarditis and osteomyelitis caused by susceptible organisms.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Vomiting - Metallic taste - Insomnia

Serious or Rare Side Effects: - Thrombocytopenia - Peripheral neuropathy - Serotonin syndrome - Lactic acidosis - Optic neuritis - Severe allergic reactions (e.g., anaphylaxis)

When prescribing Linezolid, clinicians should consider several safety aspects. - Renal impairment: assess renal function and adjust therapy if needed. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Hematologic monitoring: regularly check platelet counts for thrombocytopenia. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Linezolid interacts with several drug classes and requires careful management.

Major Interactions (Avoid): - Serotonergic agents (SSRIs, SNRIs, MAO inhibitors): risk of serotonin syndrome. - MAO inhibitors: may cause hypertensive crisis. - Tyramine‑rich foods: can precipitate hypertensive episodes. - Rifampin: reduces linezolid plasma concentrations. - Protease inhibitors (e.g., ritonavir): increase risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - NSAIDs: increased bleeding risk. - Carbamazepine: induces metabolism, may lower linezolid levels. - Oral contraceptives: possible reduction in efficacy, advise alternative contraception.